TriMas Corporation

TriMas Corporation (TRS) Market Cap

TriMas Corporation has a market capitalization of $1.40B.

Price: $39.17

-0.38 (-0.96%)

Market Cap: 1.40B

NASDAQ · time unavailable

CEO: Thomas J. Snyder

Sector: Consumer Cyclical

Industry: Packaging & Containers

IPO Date: 2007-05-18

Website: https://www.trimascorp.com

TriMas Corporation (TRS) - Company Information

Market Cap: 1.40B|Sector: Consumer Cyclical

Company Profile

TriMas Corporation designs, develops, manufactures, and sells products for consumer products, aerospace, and industrial markets worldwide. It operates through three segments: Packaging, Aerospace, and Specialty Products. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, flexible spouts, and agricultural closures; polymeric jar products; integrated dispensers; bag-in-box products; aseptic closures; industrial closures and flex spouts; custom injection molded components and devices; various injection molded products; and single-bodied and assembled caps and closures under the Rieke, Taplast, Affaba & Ferrari, Stolz, Omega, and Rapak brands. The Aerospace segment provides fasteners, collars, blind bolts, rivets, ducting, and connectors for air management systems, and machined parts and components to original equipment manufacturers, supply chain distributors, MRO/aftermarket providers, and tier one suppliers; and military and defense aerospace applications and platforms under the Monogram Aerospace Fasteners, Allfast Fastening Systems, Mac Fasteners, TFI Aerospace, RSA Engineered Products, and Martinic Engineering brands. The Specialty Products segment offers steel cylinders for use in the transportation, storage, and dispensing of compressed gases under the Norris Cylinder brand; natural gas powered wellhead engines, compressors, and replacement parts for oil and natural gas production, and other industrial and commercial markets under the Arrow brand; and spare parts for various industrial engines. The company sells its products through a direct sales force, third-party agents, and distributors. TriMas Corporation was incorporated in 1986 and is headquartered in Bloomfield Hills, Michigan.

Analyst Sentiment

92%
Strong Buy

From 2 Active Polls

1Y Forecast: $38.00

▼ -3.0% Potential Upside

Consensus Target Metrics

Low Bound

$38

Median

$38

High Bound

$38

Average

$38

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$38.00
▼ -2.99% Upside
Low Target
$38.00
-3% Risk
Median Target
$38.00
-3% Mid
High Target
$38.00
-3% Max
Consensus
Buy
7 / 14 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)1,4031,3451,4051,5711,1639519981,0371,023
Enterprise Value ($M)5334751,8801,9921,6071,4031,4171,4661,459
Price to Earnings Ratio (P/E)1.610.424.3042.2217.3919.1544.22102.4523.37
Price/Earnings-to-Growth Ratio (PEG)0.050.2210.503.96
Price to Sales Ratio (P/S)1.627.999.045.834.236.246.664.524.25
Price to Book Ratio (P/B)1.010.931.992.171.631.391.501.521.51
Price to Free Cash Flow Ratio (P/FCF)29.09-54.6838.1668.8388.03-253.7082.45102.05136.37
Enterprise Value to Sales (EV/Sales)2.8212.097.405.859.209.476.396.07
Enterprise Value to EBITDA (EV/EBITDA)4.6118.62200.6550.7038.7271.9665.0868.5645.47
Debt to Equity Ratio-7.520.300.720.630.660.700.660.670.70

TRS Growth Runway Model

Standard long term linear growth fade

Multi-Stage Discounted Cash Flow Sandbox

Market Price$39.17
Intrinsic Value$0.00
Market Alignment
Overvalued by 33798.4%relative to calculated intrinsic value
9.00%
Exp: -6%-6%
i

Growth runway slowdown

This value provides a time window for the growth rate to decline beyond Stage 1 toward the terminal rate. Longer windows are most useful for companies with high growth starting conditions or strong competitive advantages. This option stretches out the growth rate slowdown across 5, 10, or 15-year steps. A high-growth starting condition (exceeding a 25% initial growth rate) automatically applies a curve decay to simulate realistic, rapid market saturation.
i

Terminal growth rate

With long-term inflation between 3-5%, revenue must grow by that baseline to maintain flat real-world market share. This value sets the permanent terminal growth rate to factor into the valuation beyond the growth slowdown runway toward maturity.

3-Stage Financial Runway Horizon

🧠 Perpetuity Horizon Engine (Stage 3: Post-2035)

Terminal FCF Base$0.03B
Perpetuity TV Value$0.57B
Discounted TV (PV)$0.24B
TV Weighting %54.0%
⚠️
Financial Model Disclaimer & Risk Disclosure: This interactive scenario simulator is an educational sandbox provided strictly for informational and analytical research purposes. Core historical financial statements and consensus estimates are sourced directly via Financial Modeling Prep (FMP). All downstream outputs are entirely deterministic, hypothetical projections generated by combining automated mathematical formulas (including linear interpolation and Gaussian bell-curve decay models) with user-selected variables and third-party financial data inputs. Users assume all liability for trading decisions executed based on these sandbox calculations.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 TRIMAS CORP (TRS) — Investment Overview

🧩 Business Model Overview

TriMas is an engineered-products manufacturer and supplier serving a range of industrial and end-market customers. The business model centers on designing, producing, and qualifying specialty components that get incorporated into customers’ finished products (rather than selling generic commodities). Value creation comes from (1) translating customer application requirements into manufacturable designs, (2) maintaining stable quality at scale, and (3) supporting customers through the qualification cycle and ongoing production volumes.

Customer stickiness typically arises because TriMas’ offerings are embedded in customers’ product engineering and supply chains, where approvals, performance specifications, and documentation requirements limit frequent substitution.

💰 Revenue Streams & Monetisation Model

TriMas monetizes through a mix of contract-like program revenue and ongoing production shipments tied to customer demand. Pricing generally reflects a combination of:

  • Unit economics from manufacturing execution (yield, labor productivity, throughput).
  • Pass-through and mix (ability to manage input cost volatility and capitalize on favorable product mix).
  • Application-specific differentiation (engineering-led components that command premiums versus commodity alternatives).

While revenue can be cyclical with end-market production levels, the company’s engineered positioning supports comparatively higher gross margin quality than purely commodity suppliers, assuming execution and customer retention remain intact.

🧠 Competitive Advantages & Market Positioning

TriMas’ moat is best framed as switching costs and manufacturing/qualification capability, reinforced by cost advantages from scale and process know-how in specialized product categories. Competitors can introduce new products, but displacing an approved supplier often requires technical requalification, tooling/validation, and supply chain redesign—items that slow customer switching and support retention.

  • Switching costs (qualification + documentation + performance requirements): Once designs are specified and performance standards are met, requalification risk and administrative overhead create friction for buyers.
  • Manufacturing competence: Specialized processes, quality systems, and repeatable output reduce customer risk.
  • Intangible asset accumulation: Long-term relationships and application-specific engineering know-how build a track record that is difficult to replicate quickly.

COMPETITIVE BENCHMARKING (Primary competitors)

  • AptarGroup: Strong position in engineered drug delivery and dosage systems. Aptar often emphasizes deep end-market specialization in specific healthcare packaging/delivery categories; TriMas competes where engineering-enabled solutions and customer qualification matter, but with a broader engineered-products orientation.
  • Berry Global: Larger scale across packaging plastics and related products. Berry’s advantage is breadth and scale in packaging; TriMas typically emphasizes engineered, application-specific components where technical requirements and qualification cycles create stickiness.
  • RPC Group (and similar specialty packaging manufacturers): Focus on engineered rigid packaging and components. RPC competes on design capability and customer engagement; TriMas differentiates through a portfolio mix and manufacturing execution suited to customers seeking qualified engineered suppliers rather than purely standardized offerings.

🚀 Multi-Year Growth Drivers

Key growth drivers over a 5–10 year horizon are primarily structural rather than dependent on near-term market timing:

  • Outsourcing of engineered components: Customers increasingly seek specialized suppliers that can manage design-to-production execution.
  • Higher specification requirements: Quality systems, performance standards, and documentation requirements increase the value of qualified suppliers and raise barriers to entry.
  • Product mix shift toward engineered differentiation: Application complexity and regulatory/consumer performance expectations tend to favor engineered solutions over commodity inputs.
  • Supply-chain resilience and geographic preference: Buyers often favor established suppliers capable of consistent production and responsive sourcing, supporting demand durability for qualified providers.
  • Process and efficiency improvements: Continuous manufacturing optimization can expand operating margins even in mature end markets, provided input cost and utilization are managed.

⚠ Risk Factors to Monitor

  • End-market cyclicality: Engineered component demand typically tracks industrial production and customer build schedules.
  • Input cost volatility: Resins, metals, energy, and logistics can pressure margins if contracts or pricing power do not offset costs.
  • Customer concentration and program timing: Revenue can be influenced by customer sourcing strategies, launch timing, and volume ramps.
  • Execution risk in capacity and integrations: Manufacturing expansions, process changes, and portfolio reshaping require disciplined capital allocation and operational management.
  • Regulatory and compliance requirements: For healthcare-adjacent applications, adherence to quality and documentation standards is essential and failure can impair customer relationships.

📊 Valuation & Market View

Equity valuation for engineered industrial and packaging-adjacent manufacturers commonly anchors to EV/EBITDA and earnings power, with investors underwriting:

  • Margin durability (gross margin quality, operating leverage, and cost pass-through ability).
  • Free cash flow conversion (working capital discipline and capex efficiency).
  • Customer retention and program stability (evidence of sustained qualification and repeat ordering).
  • Credible growth pathways (new program wins, mix shift, and efficiency initiatives).

Because TriMas operates across multiple engineered product categories, market participants often apply a discount or premium based on perceived segment synergy, end-market diversification, and confidence in sustainable execution.

🔍 Investment Takeaway

TriMas is best viewed as an engineered supplier where qualification-driven switching costs, manufacturing execution capability, and application-specific differentiation support durable customer relationships. The long-term investment case rests on the ability to maintain margin quality through input-cycle volatility, win and retain engineered programs, and convert operational improvements into steadier free cash flow—while managing the inherent cyclicality of served end markets.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for TRS.

seekingalpha.com2026-04-30

TriMas Corporation (TRS) Q1 2026 Earnings Call Transcript

TriMas Corporation (TRS) Q1 2026 Earnings Call Transcript

zacks.com2026-04-30

TriMas (TRS) Q1 Earnings and Revenues Surpass Estimates

TriMas (TRS) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.46 per share a year ago.

businesswire.com2026-04-30

TriMas Reports First Quarter 2026 Results

BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--TriMas (NASDAQ: TRS) today announced financial results for the first quarter ended March 31, 2026. TriMas reported first quarter 2026 net sales of $168.3 million, a 10.4% increase compared to $152.5 million in first quarter 2025, driven by organic growth in both Packaging and Specialty Products, as well as the benefit of favorable foreign currency exchange. The Company reported operating profit of $6.9 million in first quarter 2026, compared to $7.2 mil.

zacks.com2026-04-27

Is the Options Market Predicting a Spike in TriMas Stock?

Investors need to pay close attention to TRS stock based on the movements in the options market lately.

businesswire.com2026-04-23

TriMas Declares Quarterly Dividend

BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--TriMas (NASDAQ: TRS) announced today that its Board of Directors declared a quarterly cash dividend of $0.04 per share of TriMas Corporation stock. The quarterly dividend is payable on May 14, 2026, to shareholders of record as of the close of business on May 7, 2026. About TriMas TriMas designs, manufactures and supplies a broad range of innovative and high‑quality products for the consumer packaging, life sciences and industrial markets through its Tr.

businesswire.com2026-04-07

Trimas Announces First Quarter 2026 Earnings Conference Call Date

BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--TriMas (NASDAQ: TRS) today announced that it will hold its first quarter 2026 earnings conference call on Thursday, April 30, 2026, at 10 a.m. Eastern Time. The call will follow the Company's release of its earnings results earlier that morning at 8:00 a.m. Eastern Time. Earnings Call Access: U.S. & Canada: (877) 407‑0890 International: +1 (201) 389‑0918 Request: TriMas First Quarter 2026 Earnings Call Webcast & slides: Available at www.trimas.c.

defenseworld.net2026-04-04

TriMas Corporation $TRS Shares Acquired by SG Americas Securities LLC

SG Americas Securities LLC grew its position in TriMas Corporation (NASDAQ: TRS) by 505.8% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 84,639 shares of the industrial products company's stock after purchasing an additional 70,667 shares during the period. SG

businesswire.com2026-03-16

TriMas Completes the Divestiture of TriMas Aerospace

BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--TriMas (NASDAQ: TRS) today announced that it has completed the previously announced divestiture of the TriMas Aerospace business (“TriMas Aerospace”) to PennAero, a portfolio company of Tinicum L.P. and funds managed by Blackstone, Inc. The transaction, first disclosed on November 4, 2025, was completed for approximately $1.45 billion in cash, subject to customary post‑closing adjustments, with estimated net after-tax proceeds of approximately $1.2 bill.

defenseworld.net2026-03-14

TriMas Corporation $TRS Shares Acquired by Alpha Wave Global LP

Alpha Wave Global LP increased its position in shares of TriMas Corporation (NASDAQ: TRS) by 363.7% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 342,342 shares of the industrial products company's stock after acquiring an additional 268,510

defenseworld.net2026-03-12

Capital International Investors Takes Position in TriMas Corporation $TRS

Capital International Investors bought a new position in shares of TriMas Corporation (NASDAQ: TRS) in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 2,890,079 shares of the industrial products company's stock, valued at approximately $111,673,000. Capital International Investors

defenseworld.net2026-03-08

TriMas Corporation $TRS Shares Sold by Barington Companies Management LLC

Barington Companies Management LLC cut its stake in TriMas Corporation (NASDAQ: TRS) by 55.7% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 275,000 shares of the industrial products company's stock after selling 346,000 shares during the quarter. TriMas comprises

zacks.com2026-03-03

Here's Why TriMas (TRS) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

defenseworld.net2026-03-02

TriMas Q4 Earnings Call Highlights

TriMas (NASDAQ: TRS) executives told investors the company is nearing a major portfolio shift and expects 2026 to mark an important first step in a multi-year margin improvement effort, following what management described as a "transitional year" in 2025. On the company's fourth-quarter and full-year 2025 earnings call, President and CEO Thomas Snyder and Chief Financial

zacks.com2026-02-27

TriMas Earnings Fall Short of Estimates in Q4, Revenues Increase Y/Y

TRS Q4 EPS of 40 cents misses estimates as margins narrow, but revenues rise 12.5% y/y and 2026 growth of 3-6% signals steady demand ahead.

seekingalpha.com2026-02-26

TriMas Corporation (TRS) Q4 2025 Earnings Call Transcript

TriMas Corporation (TRS) Q4 2025 Earnings Call Transcript

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2025-12-31

"For the fiscal year ended 2025, TRS reported a revenue of $155.49M and net income of $81.7M, resulting in earnings per share (EPS) of $2.06. Operating cash flow was robust at $117.37M, with free cash flow amounting to $69.07M, showcasing strong operational efficiency. The company maintains a healthy balance sheet with total assets valued at $1.49B compared to total liabilities of $779.49M, yielding total equity of $705.59M, which reflects a solid financial foundation. Notably, TRS's stock price has appreciated by 55% over the past year, underscoring strong market sentiment despite a slight year-to-date gain of 0.88%. While dividends paid totaled $6.61M, the significant price increase indicates strong shareholder returns primarily driven by price appreciation rather than dividend yield. The current market price stands at $36.61, with a consensus price target of $38, indicating upside potential. Overall, TRS demonstrates strong growth potential, solid profitability, and a robust cash flow position."

Revenue Growth

Good

Impressive revenue growth at $155.49M, reflecting robust operational performance.

Profitability

Good

Strong profitability with net income of $81.7M and a solid EPS of $2.06.

Cash Flow Quality

Strong

Healthy operating cash flow of $117.37M and free cash flow of $69.07M.

Leverage & Balance Sheet

Good

Strong balance sheet with total assets of $1.49B and equity of $705.59M against liabilities.

Shareholder Returns

Strong

Significant price appreciation of 55% over the last year, indicating strong returns for shareholders.

Analyst Sentiment & Valuation

Positive

Positive sentiment with a price target of $38, showing expected upside from the current price.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

So What? TriMas started 2026 with stronger-than-expected operating execution: Q1 net sales rose >10% YoY to $168M and operating margin expanded 120 bps, beating original Q1 assumptions. Adjusted EPS jumped 60% to $0.24, supported not only by operating leverage and early cost-streamlining/corporate cash cost reductions, but also by ~$0.04/share of interest income from Aerospace proceeds. Management also reaffirmed a clear 2026 framework: 3%–6% sales growth, >300 bps operating margin expansion to ~14%–15%, and $1.50–$1.70 adjusted diluted EPS, with explicit assumptions for interest income, tax rate (27%–29%), and corporate cash expense reduction (~$10M). The key debate in Q&A centered on commodity pass-through timing (likely Q2 shortfall recovered by Q3) and Packaging margin cadence amid mix effects from a one-time low-margin tooling sale—management indicated no similar tooling pressure is forecast for the rest of the year. Net outcome: positive, with a near-term timing risk rather than a fundamental demand issue.

AI IconGrowth Catalysts

  • Packaging: Q1 net sales +9.1% YoY to $139.2M driven by organic gains (7.3%) plus a 4% currency tailwind
  • Packaging: strength in beauty/personal care and life sciences offset by industrial closure softness
  • Specialty Products: Norris Cylinder net sales +24% YoY with stronger intake, market share gains, and improving demand trends
  • Norris Cylinder margin expansion: operating margin 9.8% (up 940 bps YoY) from higher volumes and improved fixed cost absorption
  • Cost-out and operational excellence: early benefits plus standardization/Lean Six Sigma initiatives contributing to operating leverage

Business Development

  • TriMas Aerospace divestiture closed March 16 (transaction completed on schedule; Arrow Engine divestiture impact referenced as modest in Q1 net sales and closed Jan 2025)
  • Program-related tooling sale: Q1 included nearly $5M of tooling revenue at life sciences with low margin, not inherent in original Q1 forecast (customer program timing into production later in year/early next year)

AI IconFinancial Highlights

  • Consolidated Q1: net sales increased >10% YoY to $168M; growth drivers were 7.3% organic, +4% currency tailwind, partially offset by modest Arrow Engine divestiture impact
  • Operating margin: expanded 120 bps YoY and exceeded original Q1 assumptions (operating profit increased; margin expansion attributed to operating leverage and early cost-streamlining/corporate cash cost reductions)
  • Adjusted EPS: +60% YoY to $0.24 from $0.15
  • Income from continuing operations: +51% to $9M from $5.9M
  • Interest income benefit: approximately $0.04 per share from invested divestiture proceeds
  • Effective tax rate: increased YoY and partially offset operating/interest income benefits
  • Segment margin optics: Packaging operating profit $17.7M; margins lower YoY due to unfavorable mix, especially higher tooling revenue that moderated volume/cost benefits

AI IconCapital Funding

  • Aerospace proceeds: received ~$1.4B gross cash proceeds (vs >$1.2B net after-tax proceeds mentioned for after-tax net proceeds)
  • Share repurchases: repurchased nearly 1.5M shares in Q1; total repurchases since Aerospace divestiture announcement ~4.5M shares
  • Proceeds deployed to buybacks: over $150M deployed between Nov 2025 and end of Q1
  • Taxes: expects to fund ~$200M income taxes owed related to transaction gain beginning Q2
  • Net cash position: $913M at quarter end
  • Debt: $400M 4.125% senior notes due 2029 (stable low-cost financing)
  • Free cash flow: Q1 free cash flow was a use of $16M (seasonal)

AI IconStrategy & Ops

  • Cost-out targets reiterated/updated: approximately $10M of cost savings in 2026 and $15M annually (actions progressing as planned)
  • Manufacturing footprint consolidation: plans to consolidate Atkins, Arkansas packaging facility into other locations by mid-year '26
  • Expected additional savings from consolidation: ~$0.5M in 2026 and ~$1.0M annualized
  • Operational improvement emphasis: intensified focus on standardization, operational excellence, continuous improvement; embedding Lean Six Sigma across manufacturing footprint
  • Geopolitical/cost pressure management: Middle East developments monitored; managing impacts via coordination with vendors/customers

AI IconMarket Outlook

  • Full-year 2026 sales growth guidance reaffirmed: 3% to 6% (based on $645.7M 2025 revenue base)
  • Full-year 2026 operating margin expansion: more than 300 bps relative to 5.3% 2025 margin, implying ~14% to 15% operating margins
  • Full-year 2026 adjusted diluted EPS guidance: $1.50 to $1.70 (191% increase at midpoint vs $0.55 in 2025)
  • Guidance assumptions for remainder of 2026: ~$9M interest income for remaining quarter(s); no significant changes in interest rates
  • Guidance inputs: interest expense $20M to $22M; corporate cash expense reduction ~ $10M YoY; effective tax rate 27% to 29%
  • Quarterly cadence expectation: sequential improvement in sales/earnings/adjusted EPS in each quarter of 2026 vs prior year, with sequential earnings growth in Q2 then Q3

AI IconRisks & Headwinds

  • Commodity price pass-through timing risk: resin cost recovery lag possible; contracts primarily quarterly, with potential delay where recovery may be short moving into Q2 and then improved in Q3 (minor full-year impact expected)
  • Volume uncertainty: Q2 vs Q3 being highest sales quarter uncertain, impacting sequential margin pattern
  • Mix headwind risk: Q1 Packaging margins were pressured by tooling revenue at low margin (no further significant tooling sale currently forecast)
  • Geopolitical/cost pressures: Middle East developments and supply chain cost pressures monitored; no significant direct impacts experienced to date

Q&A: Analyst Interest

  • Topic: Resin/commodity price pass-through lag and margin impact timing. Management emphasized resin-cost recovery is mostly under contract with cost-recovery language, predominantly on quarterly terms. They flagged potential shortfall in recovery into Q2 due to March cost movements, then expecting improvement/overcoming in Q3; overall full-year impact not expected to be material.
  • Topic: Packaging margin cadence through 2026 given cost savings plus mix effects. Management reiterated a sequential margin increase profile: Q1 lowest, then escalation through next two quarters; Q4 naturally softens but should remain in line with full-year guidance. They acknowledged sales-volume uncertainty could shift whether Q2 or Q3 is highest but expect cost-out actions to support cadence.
  • Topic: Tooling revenue mix pressure in Q1 and whether similar impacts recur. Management explained Q1 included nearly $5M life-sciences tooling revenue created/sold at low margin, which was not inherent in original Q1 forecast and pressured margins. They said no other significant tooling sales are currently forecast for the remainder of 2026, so they do not expect further tooling-driven margin pressure.

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the TRS Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for TRS.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (TRS)

© 2026 Stock Market Info — TriMas Corporation (TRS) Financial Profile